Myocardial extracellular matrix remodeling in ischemic heart failure

Frontiers in Bioscience

Volumn 12, Issue 4, 2007, Pages 1410-1419

  Gallagher, Gabrielle L ^a,c   Jackson, Christopher J ^b   Hunyor, Stephen N ^a  

^a Kolling Institute of Medical Research   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Collagen; Extracellular matrix; Heart failure; Matrix metalloproteinases; Myocardial infarction; Review

Indexed keywords

ANIMALIA;

EID: 34249826051     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2157     Document Type: Article

References (71)

1. Pfeffer, M. A. & E. Braunwald: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation., 81, 1161-72 (1990)
2. Anand, I. S. & J. N. Cohn: Introduction. Journal of Cardiac Failure., 8, S247 (2002)
3. Huang, Y., S. N. Hunyor, L. Jiang, O. Kawaguchi, K. Shirota, Y. Ikeda, T. Yuasa, G. Gallagher, B. Zeng & X. Zheng: Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. American Journal of Physiology - Heart & Circulatory Physiology, 286, H2141-50 (2004)
4. Cleutjens, J. P.: The role of matrix metalloproteinases in heart disease.[comment]. Cardiovascular Research., 32, 816-21 (1996)
5. Weber, K. T.: Cardiac interstitium in health and disease: the fibrillar collagen network. Journal of the American College of Cardiology., 13, 1637-52 (1989)
6. Terracio, L. & T. K. Borg: Factors affecting cardiac cell shape. Heart Failure, 4, 114-24 (1988)
7. Kuettner, K. E. & J. H. Kimura: Proteoglycans: an overview. Journal of Cellular Biochemistry., 27, 327-36 (1985)
8. Alberts, B., A. Johnson, J. Lewis, M. Raff, K. Roberts & P. Walter: Molecular Biology of the Cell. Garland Science, New York (2002)
9. Caulfield, J. B. & T. K. Borg: The collagen network of the heart. Laboratory Investigation., 40, 364-72 (1979)
10. O'Brien, L. J. & C. M. Moore: Connective tissue degradation and distensibility characteristics of the non-living heart. Experientia., 22, 845-7 (1966)
11. Caulfield, J. B., P. Norton & R. D. Weaver: Cardiac dilatation associated with collagen alterations. Molecular & Cellular Biochemistry., 118, 171-9 (1992)
12. Janicki, J. S. & G. L. Brower: The role of myocardial fibrillar collagen in ventricular remodeling and function. Journal of Cardiac Failure., 8, S319-25 (2002)
13. Baicu, C. F., J. D. Stroud, V. A. Livesay, E. Hapke, J. Holder, F. G. Spinale & M. R. Zile: Changes in extracellular collagen matrix alter myocardial systolic performance. American Journal of Physiology - Heart & Circulatory Physiology., 284, H122-32 (2003)
14. Narayan, S., J. S. Janicki, S. G. Shroff, R. Pick & K. T. Weber: Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats. American Journal of Hypertension., 2, 675-82 (1989)
15. Skosey, J. L., R. Zak, A. F. Martin, V. Aschenbrenner & M. Rabinowitz: Biochemical correlates of cardiac hypertrophy. V. Labeling of collagen, myosin, and nuclear DNA during experimental myocardial hypertrophy in the rat. Circulation Research., 31, 145-57 (1972)
16. Bonnin, C. M., M. P. Sparrow & R. R. Taylor: Collagen synthesis and content in right ventricular hypertrophy in the dog. American Journal of Physiology., 241, H708-13 (1981)
17. Doering, C. W., J. E. Jalil, J. S. Janicki, R. Pick, S. Aghili, C. Abrahams & K. T. Weber: Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovascular Research., 22, 686-95 (1988)
18. Gunja-Smith, Z., A. R. Morales, R. Romanelli & J. F. Woessner, Jr.: Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links.[comment]. American Journal of Pathology., 148, 1639-48 (1996)
19. Ikeda, Y., C. Yutani, Y. Huang, K. Masuda, T. Yuasa, O. Kawaguchi & S. N. Hunyor: Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy. Cardiovascular Pathology, 10, 19-27 (2001)
20. Sun, Y. & K. T. Weber: Infarct scar: a dynamic tissue. Cardiovascular Research., 46, 250-6 (2000)
21. Cleutjens, J. P., W. M. Blankesteijn, M. J. Daemen & J. F. Smits: The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovascular Research., 44, 232-41 (1999)
22. Sun, Y. & K. T. Weber: Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. Journal of Molecular & Cellular Cardiology., 28, 851-8 (1996)
23. Willems, I. E., M. G. Havenith, J. G. De Mey & M. J. Daemen: The alpha-smooth muscle actin-positive cells in healing human myocardial scars. American Journal of Pathology., 145, 868-75 (1994)
24. Volders, P. G., I. E. Willems, J. P. Cleutjens, J. W. Arends, M. G. Havenith & M. J. Daemen: Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. Journal of Molecular & Cellular Cardiology., 25, 1317-23 (1993)
25. Sato, S., M. Ashraf, R. W. Millard, H. Fujiwara & A. Schwartz: Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. Journal of Molecular & Cellular Cardiology., 15, 261-75 (1983)
26. Swynghedauw, B.: Molecular mechanisms of myocardial remodeling. Physiological Reviews., 79, 215-62 (1999)
27. Galis, Z. S., M. Muszynski, G. K. Sukhova, E. Simon-Morrissey, E. N. Unemori, M. W. Lark, E. Amento & P. Libby: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circulation Research., 75, 181-9 (1994)
28. Tyagi, S. C., S. Kumar & G. Glover: Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. Journal of Cellular Biochemistry., 58, 360-71 (1995)
29. Coker, M. L., M. A. Doscher, C. V. Thomas, Z. S. Galis & F. G. Spinale: Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. American Journal of Physiology., 211, H777-87 (1999)
30. Tyagi, S. C., L. Matsubara & K. T. Weber: Direct extraction and estimation of collagenase (s) activity by zymography in microquantities of rat myocardium and uterus. Clinical Biochemistry., 26, 191-8 (1993)
31. Spinale, F. G., H. Gunasinghe, P. D. Sprunger, J. M. Baskin & W. C. Bradham: Extracellular degradative pathways in myocardial remodeling and progression to heart failure. Journal of Cardiac Failure., 8, S332-8 (2002)
32. Li, Y. Y., A. M. Feldman, Y. Sun & C. F. McTiernan: Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation., 98, 1728-34 (1998)
33. Siwik, D. A., D. L. Chang & W. S. Colucci: Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circulation Research., 86, 1259-65 (2000)
34. Li, Y. Y., Y. Feng, C. F. McTiernan, W. Pei, C. S. Moravec, P. Wang, W. Rosenblum, R. L. Kormos & A. M. Feldman: Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.[comment]. Circulation., 104, 1147-52 (2001)
35. Guo, C. & L. Piacentini: Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. The Journal of Biological Chemistry, 278, 46699-708 (2003)
36. Rohde, L. E., M. Aikawa, G. C. Cheng, G. Sukhova, S. D. Solomon, P. Libby, J. Pfeffer, M. A. Pfeffer & R. T. Lee: Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. Journal of the American College of Cardiology., 33, 835-42 (1999)
37. Squire, I. B., J. Evans, L. L. Ng, I. M. Loftus & M. M. Thompson: Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. Journal of Cardiac Failure, 10, 328-33 (2004)
38. Butt, R. P. & J. E. Bishop: Mechanical load enhances the stimulatory effect of serum growth factors on cardiac fibroblast procollagen synthesis. Journal of Molecular & Cellular Cardiology., 29, 1141-51 (1997)
39. Nawata, J., I. Ohno, S. Isoyama, J. Suzuki, S. Miura, J. Ikeda & K. Shirato: Differential expression of alpha 1, alpha 3 and alpha 5 integrin subunits in acute and chronic stages of myocardial infarction in rats. Cardiovascular Rerearch., 43, 371-81 (1999)
40. Maquart, F. X., L. Pickart, M. Laurent, P. Gillery, J. C. Monboisse & J. P. Borel: Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters., 238, 343-6 (1988)
41. Borg, K. T., W. Burgess, L. Terracio & T. K. Borg: Expression of Metalloproteinases by Cardiac Myocytes and Fibroblasts In vitro. Cardiovascular Pathology, 6, 261-9 (1997)
42. Yarbrough, W. M., R. Mukherjee, G. P. Escobar, J. T. Mingoia, J. A. Sample, J. W. Hendrick, K. B. Dowdy, J. E. McLean, A. S. Lowry, T. P. O'Neill & F. G. Spinale: Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation., 108, 1753-9 (2003)
43. Hayashi, M., T. Tsutamoto, A. Wada, T. Tsutsui, C. Ishii, K. Ohno, M. Fujii, A. Taniguchi, T. Hamatani, Y. Nozato, K. Kataoka, N. Morigami, M. Ohnishi, M. Kinoshita & M. Horie: Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.[comment]. Circulation., 107, 2559-65 (2003)
44. Montfort, I. & R. Perez-Tamayo: The distribution of collagenase in normal rat tissues. Journal of Histochemistry & Cytochemistry., 23, 910-20 (1975)
45. Tyagi, S. C., S. E. Campbell, H. K. Reddy, E. Tjahja & D. J. Voelker: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Molecular & Cellular Biochemistry., 155, 13-21 (1996)
46. Rohde, L. E., A. Ducharme, L. H. Arroyo, M. Aikawa, G. H. Sukhova, A. Lopez-Anaya, K. F. McClure, P. G. Mitchell, P. Libby & R. T. Lee: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation., 99, 3063-70 (1999)
47. Lindsey, M. L., J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell & R. T. Lee: Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation., 105, 753-8 (2002)
48. Yarbrough, W. M., R. Mukherjee, T. A. Brinsa, K. B. Dowdy, A. A. Scott, G. P. Escobar, C. Joffs, D. G. Lucas, F. A. Crawford, Jr. & F. G. Spinale: Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs. Journal of Thoracic & Cardiovascular Surgery., 125, 602-10 (2003)
49. Deten, A., H. C. Volz, W. Briest & H. G. Zimmer: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Research, 55, 329-40 (2002)
50. Heymans, S., A. Luttun, D. Nuyens, G. Theilmeier, E. Creemers, L. Moons, G. D. Dyspersin, J. P. Cleutjens, M. Shipley, A. Angellilo, M. Levi, O. Nube, A. Baker, E. Keshet, F. Lupu, J. M. Herbert, J. F. Smits, S. D. Shapiro, M. Baes, M. Borgers, D. Collen, M. J. Daemen & P. Carmeliet: Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.[comment]. Nature Medicine., 5, 1135-42 (1999)
51. Ducharme, A., S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L. E. Rohde, F. J. Schoen, R. A. Kelly, Z. Werb, P. Libby & R. T. Lee: Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. Journal of Clinical Investigation., 106, 55-62 (2000)
52. Jayasankar, V., Y. J. Woo, L. T. Bish, T. J. Pirolli, M. F. Berry, J. Burdick, R. C. Bhalla, R. V. Sharma, T. J. Gardner & H. L. Sweeney: Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation, 110, II180-6(2004)
53. Tziakas, D. N., G. K. Chalikias, J. T. Parissis, E. I. Hatzinikolaou, E. D. Papadopoulos, G. A. Tripsiannis, E. G. Papadopoulou, I. K. Tentes, S. M. Karas & D. I. Chatseras: Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. International Journal of Cardiology, 94, 269-77 (2004)
54. Wilson, E. M., H. R. Gunasinghe, M. L. Coker, P. Sprunger, D. Lee-Jackson, B. Bozkurt, A. Deswal, D. L. Mann & F. G. Spinale: Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. Journal of Cardiac Failure., 8, 390-8 (2002)
55. Cleland, J. G., A. P. Coletta, N. Freemantle, P. Velavan, L. Tin & A. L. Clark: Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. European Journal of Heart Failure, 7, 931-6 (2005)
56. Zucker, S., J. Cao & W. T. Chen: Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19, 6642-50 (2000)
57. Herzog, E., A. Gu, T. Kohmoto, D. Burkhoff & J. S. Hochman: Early Activation of Metalloproteinases after Experimental Myocardial Infarction Occurs in Infarct and Non-infarct Zones. Cardiovascular Pathology, 7, 307-312 (1998)
58. Cleutjens, J. P., J. C. Kandala, E. Guarda, R. V. Guntaka & K. T. Weber: Regulation of collagen degradation in the rat myocardium after infarction. Journal of Molecular & Cellular Cardiology., 27, 1281-92 (1995)
59. Wilson, E. M., S. L. Moainie, J. M. Baskin, A. S. Lowry, A. M. Deschamps, R. Mukherjee, T. S. Guy, M. G. St John-Sutton, J. H. German, 3rd, L. H. Edmunds, Jr., R. C. German & F. G. Spinale: Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation., 107, 2857-63 (2003)
60. Coker, M. L., J. L. Zellner, A. J. Crumbley & F. G. Spinale: Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy. Annals of the New York Academy of Sciences., 878, 559-62 (1999)
61. Spinale, F. G., M. L. Coker, L. J. Heung, B. R. Bond, H. R. Gunasinghe, T. Etoh, A. T. Goldberg, J. L. Zellner & A. J. Crumbley: A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.[comment]. Circulation., 102, 1944-9 (2000)
62. Deten, A., H. C. Volz, A. Holzl, W. Briest & H. G. Zimmer: Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats. Molecular & Cellular Biochemistry, 251, 127-37 (2003)
63. Deten, A., A. Holzl, M. Leicht, W. Barth & H. G. Zimmer: Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. Journal of Molecular & Cellular Cardiology, 33, 1191-207 (2001)
64. Gaertner, R., M. P. Jacob, F. Prunier, E. Angles-Cano, J. J. Mercadier & J. B. Michel: The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat. Journal of Molecular & Cellular Cardiology, 38, 193-204 (2005)
65. Etoh, T., C. Joffs, A. M. Deschamps, J. Davis, K. Dowdy, J. Hendrick, S. Baicu, R. Mukherjee, M. Manhaini & F. G. Spinale: Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. American Journal of Physiology - Heart & Circulatory Physiology., 281, H987-94 (2001)
66. Deschamps, A. M., W. M. Yarbrough, C. E. Squires, R. A. Allen, D. M. McClister, K. B. Dowdy, J. E. McLean, J. T. Mingoia, J. A. Sample, R. Mukherjee & F. G. Spinale: Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation, 111, 1166-74(2005)
67. Romanic, A. M., C. L. Burns-Kurtis, B. Gout, I. Berrebi-Bertrand & E. H. Ohlstein: Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sciences, 68, 799-814 (2001)
68. Mukherjee, R., T. A. Brinsa, K. B. Dowdy, A. A. Scott, J. M. Baskin, A. M. Deschamps, A. S. Lowry, G. P. Escobar, D. G. Lucas, W. M. Yarbrough, M. R. Zile & F. G. Spinale: Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation., 107, 618-25 (2003)
69. Podesser, B. K., D. A. Siwik, F. R. Eberli, F. Sam, S. Ngoy, J. Lambert, K. Ngo, C. S. Apstein & W. S. Colucci: ET (A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat. American Journal of Physiology - Heart & Circulatory Physiology, 280, H984-91 (2001)
70. Sun, Y., J. Q. Zhang, J. Zhang & S. Lamparter: Cardiac remodeling by fibrous tissue after infarction in rats. Journal of Laboratory & Clinical Medicine., 135, 316-23 (2000)
71. Barton, P. J., E. J. Birks, L. E. Felkin, M. E. Cullen, M. U. Koban & M. H. Yacoub: Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. Journal of Heart & Lung Transplantation, 22, 738-44 (2003)